Rutgers, The State University of New Jersey
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Rutgers, The State University of New Jersey sits in the top decile of US sponsors by registered trial count (#86 of 15,742 sponsors by registered trial count).
Rutgers, The State University of New Jersey: 413 sponsored US clinical trials, 109 recruiting.
Rutgers, The State University of New Jersey sponsors 413 registered US clinical trials on ClinicalTrials.gov, 109 of them currently recruiting, and 196 completed. 35 of these trials are in Phase 3-4 (later-stage) and 104 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 6 trials.
Top-decile sponsor footprint
Rutgers, The State University of New Jersey ranks in the top decile of sponsors by registered trial count (#86 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
196 of 267 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (73.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
413 total, page 4 of 9
Virtual Reality Treatment for Emerging Adults With ADHD
NCT06454604
Developing and Testing a Nurse-Led Technology-Enhanced Family Engagement Program
NCT06128655
LUNGevity: Lung Cancer Stigma Community Based Participatory Research
NCT06286592
Dismantling the U.S. Social Norm of the "Kids' Food" Archetype (REACH Project)
NCT06266533
Translating Data Science to Palliative Care
NCT05942040
Search to Advance Limited Use of Opioids Pilot: Optimization of Non-Opioid Therapy With a Steroid
NCT06074263
Pilot Testing Dementia-Enhanced Training and Tool for Home Hospice Clinicians
NCT05719077
Choices About Genetic Testing And Learning Your Risk With Smart Technology
NCT06184867
Supplementing Brief Psychotherapy With a Mobile App
NCT05867316
Novel Treatment for Dental Ankylosis
NCT05695105
Acute Exercise on Brain Insulin Sensitivity
NCT05853913
Management of Postpartum Preeclampsia
NCT05775744
Sleep Treatment for Teens
NCT05397353
Validating Promoted Spiritual Experience
NCT05485181
Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi Syndrome
NCT05541003
Astringency and Oral Health
NCT05819073
Immersive Virtual Reality Bicycling for Persons With Parkinson's Disease
NCT05160025
Motivations to Transplant Registry Participation
NCT05595382
Transdiagnostic Group Therapy (GBAT) for Autistic Adults With Personalized Therapeutics
NCT05512221
Povidone-Iodine for Nasal Decolonization
NCT05529173
Carbon Dioxide (CO2) and Cognitive Impairment
NCT05292378
Afferent Neurocardiac Signals, Cue Reactivity, and Cognitive Control
NCT05369169
Ready and Healthy for Kindergarten
NCT05339464
Values and Options in Cancer Care 2 (VOICE 2) A Randomized Pilot Study
NCT05352451
Neuropathy Walks (Cross-sectional)
NCT04889521
Puff Biofeedback to Reduce Smoking Reinforcement
NCT05644002
Lean and Obese: Dietary Inflammation
NCT05327868
Immersive Virtual Reality Bicycling for Healthy Adults
NCT05253703
Stress Interventions in STEM and Non-STEM
NCT05376306
PREDICT: A PBRN Feasibility Study on COVID-19 Screening in Dental Practice
NCT05123742
Heart Rate Variability Biofeedback for Smoking Cessation Treatment
NCT05224050
Impact of Menstrual Phase on Oral Glucose Sensitivity
NCT06800690
Youth-Led Intervention to Improve Blood Pressure
NCT05029687
Testing THRIVE 365 for Black Sexual Minority Men (On The Daily)
NCT05376397
Alleviating Geriatric Inpatients' Medication-related Iatrogenesis
NCT05017948
Adaptation of a Behavioral Activation Treatment to Treat Depression in Autistic Adults
NCT05030610
Family Presence on Multidisciplinary Patient Care Rounds in ICU
NCT05449990
Developing Mental Health Supports for Autistic Students
NCT04926090
Oral Rinse to Reduced Expelled Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During COVID-19 Infection
NCT04931004
Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy
NCT05034289
Effects of Equine Assisted Activities on Veterans With Post-traumatic Stress Disorder
NCT04850573
New Jersey Healthcare Essential Worker Outreach and Education Study - Testing Overlooked Occupations
NCT04766333
Effects of Feeding Schedule on the Development of ICU Delirium
NCT04870554
Topical Eucalyptus Globulus and Mentha x Piperita on Muscle Soreness in Older Adults and the Elderly
NCT04866407
Live Microbials to Boost Anti-Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Immunity Clinical Trial
NCT04847349
Immunoglobulin G Therapy Dose Optimization
NCT04818177
Transdiagnostic Group Behavioral Activation for Autistic Adults
NCT04788212
Propranolol for Challenging Behaviors in Autism
NCT04047355
Rutgers Pilot for PREDICT- Patient LAB Test
NCT05607043
Rutgers Pilot for Dental Health Care Worker SARS-CoV-2 Testing
NCT05607147
What is open in the Rutgers, The State University of New Jersey pipeline
109 recruiting of 413 indexed (26% open); 196 completed (47%).
Phase mix: 35 late (III/IV) vs 104 early (I/II) (early-phase heavy).
Top condition: Autism Spectrum Disorder (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Rutgers, The State University of New Jersey: open-pipeline peers nationwide
Peers matched on 413 registered trials and 26% open enrollment, not the therapeutic-area sidebar.
Rutgers, The State University of New Jersey sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 413 trials (± recruiting share)
- St. Jude Children's Research Hospital · 410 trials · 22% recruiting
- Takeda · 408 trials · 12% recruiting
- University of Kansas Medical Center · 408 trials · 23% recruiting
- Case Comprehensive Cancer Center · 407 trials · 14% recruiting
Sponsors near 26% open enrollment (± trial volume)
- Coherus Oncology · 27% recruiting · 15 trials
- NewAmsterdam Pharma · 27% recruiting · 15 trials
- Portland VA Medical Center · 27% recruiting · 15 trials
- White River Junction Veterans Affairs Medical Center · 27% recruiting · 15 trials
Related
What to do with this Rutgers, The State University of New Jersey page
413 registered trials is a research-attention snapshot, not an endorsement of Rutgers, The State University of New Jersey or any single study.
- 109 of Rutgers, The State University of New Jersey's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Autism Spectrum Disorder is the condition Rutgers, The State University of New Jersey studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autism Spectrum Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Rutgers, The State University of New Jersey pipeline card: 413 registered trials from official public datasets.Report a data error.